- Home
- GOVX vs MBOT Comparison
GOVX vs MBOT Comparison
Compare GOVX & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- MBOT
- Stock Information
- Founded
- GOVX 2001
- MBOT 2010
- Country
- GOVX United States
- MBOT United States
- Employees
- GOVX N/A
- MBOT N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- MBOT Medical/Dental Instruments
- Sector
- GOVX Health Care
- MBOT Health Care
- Exchange
- GOVX Nasdaq
- MBOT Nasdaq
- Market Cap
- GOVX 17.1M
- MBOT 16.7M
- IPO Year
- GOVX N/A
- MBOT N/A
- Fundamental
- Price
- GOVX $2.46
- MBOT $0.93
- Analyst Decision
- GOVX Strong Buy
- MBOT Strong Buy
- Analyst Count
- GOVX 5
- MBOT 1
- Target Price
- GOVX $14.20
- MBOT $7.00
- AVG Volume (30 Days)
- GOVX 3.6M
- MBOT 155.6K
- Earning Date
- GOVX 11-12-2024
- MBOT 11-13-2024
- Dividend Yield
- GOVX N/A
- MBOT N/A
- EPS Growth
- GOVX N/A
- MBOT N/A
- EPS
- GOVX N/A
- MBOT N/A
- Revenue
- GOVX $3,090,161.00
- MBOT N/A
- Revenue This Year
- GOVX N/A
- MBOT N/A
- Revenue Next Year
- GOVX $565.58
- MBOT N/A
- P/E Ratio
- GOVX N/A
- MBOT N/A
- Revenue Growth
- GOVX N/A
- MBOT N/A
- 52 Week Low
- GOVX $1.09
- MBOT $0.82
- 52 Week High
- GOVX $11.18
- MBOT $2.35
- Technical
- Relative Strength Index (RSI)
- GOVX 52.48
- MBOT 47.00
- Support Level
- GOVX $2.31
- MBOT $0.93
- Resistance Level
- GOVX $3.88
- MBOT $0.99
- Average True Range (ATR)
- GOVX 0.32
- MBOT 0.05
- MACD
- GOVX 0.11
- MBOT 0.00
- Stochastic Oscillator
- GOVX 33.33
- MBOT 26.20
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.